Anti-mullerian hormone levels increase after bariatric surgery in obese female patients with and without polycystic ovary syndrome
| Autor: | Mitat Buyukkaba, Seda Turgut, Mahmut Muzaffer Ilhan, Iskender Ekinci, İlhan Yaylım, Sakir Umit Zeybek, Saime Turan, Ertugrul Tasan, Ozcan Karaman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Anti-Mullerian Hormone
endocrine system diseases Endocrinology Diabetes and Metabolism Biochemistry (medical) Clinical Biochemistry Bariatric Surgery General Medicine Reproductive Functions Biochemistry female genital diseases and pregnancy complications Obesity Morbid Endocrinology Infertility Weight Loss Humans Female Prospective Studies Polycystic Ovary Syndrome |
| Popis: | This study was aimed to investigate the effect of weight loss by bariatric surgery on the level of anti-Mullerian hormone (AMH) in morbidly obese female patients with or without polycystic ovary syndrome (PCOS). This prospective study includes 70 females, obese, and fertile patients of reproductive age. All patients were evaluated to determine the changes in weight, body mass index (BMI), serum AMH, and other biochemical parameters at the end of six months. The mean levels of the preop and postop AMH were 1.66±0.87 ng/ml and 5.99±1.39 ng/ml in the PCOS group; 1.35±0.76 ng/ml and 6.23±1.47 ng/ml in the non-PCOS group, respectively. The postop AMH levels were significantly higher than the preop levels for both groups (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|